Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Greenwich LifeSciences, Inc. shareholders approved Ratification of the appointment of Malone Bailey, LLP as the independent registered public accounting firm for the fiscal year ended December 31, 2023. at the 2023-12-15 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-15
Exact text from the filing
Proposal 2. The appointment of Malone Bailey, LLP as the Company’s independent registered public accounting firm for its fiscal year ended December 31, 2023 was ratified and approved by the stockholders by the votes set forth in the table below: For Against Abstain Broker Non Vote 8,210,833 14,108 7,449 1
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Greenwich LifeSciences, Inc. shareholders approved Election of five (5) nominees for director to serve until the 2024 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. at the 2023-12-15 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-12-15
Exact text from the filing
Proposal 1 . All of the five (5) nominees for director were elected to serve until the 2024 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. The result of the votes to elect the five (5) directors was as follows: Directors For Against Abstain Broker Non Vote David McWilliams 7,005,454 0 308,802 918,135 Snehal S. Patel 7,140,753 0 173,503 918,135 Eric Rothe 7,034,141 0 280,115 918,135 F. Joseph Daugherty, M.D. 7,139,876 0 174,381 918,134 Kenneth Hallock 7,080,646 0 233,610 918,135
View on SEC.gov